PURE Bioscience Q3 net product sales up 11% YoY; net loss narrows to $580K

PURE BIOSCIENCE, INC.

2025-Q3 EPS reported -$0.02 revenue$1,435,000

Net product sales $489K in fiscal Q3 ended Apr 30, 2025, up from $440K YoY.
Net loss improved to $580K from $857K in same quarter last year.
Adjusted net loss (excl. share-based comp) was $547K vs $825K YoY.
EPS remained ($0.01) for both quarters; nine-month EPS ($0.02) vs ($0.03) last year.
CEO reports SDC dairy membrane solution now commercial at full-scale dairy plants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.